AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

INGN · NASDAQ · Medical - Devices

Inogen (INGN)

Provides portable oxygen and respiratory devices through consumer, provider, and distributor channels.

$5.10

vs last close−0.13 (−2.54%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	84	76	78	89	89	80	82	92	92	82	85	95
Cost of revenue	50	48	44	46	47	44	46	51	45	41	43	52
Gross profit	34	28	34	43	41	36	36	41	47	41	42	43
	80	57	51	50	49	48	44	47	54	51	50	48
Research & development	4	7	7	6	4	6	4	5	5	5	5	6
	43	50	44	44	46	42	40	42	44	39	42	42
Selling & marketing	26	26	27	26	26	24	24	25	25	23	25	25
General & administrative	17	25	17	19	19	18	16	17	18	16	17	18
Other expenses	33	0	0	0	0	0	0	0	6	6	3	0
Operating income	−47	−29	−16	−7	−8	−11	−8	−6	−7	−9	−8	−5
	1	2	2	1	2	1	1	2	2	2	0	1
Interest income	2	2	1	1	1	1	1	1	1	1	1	1
Other non-operating income	−33	−2	−2	−1	−2	−1	−1	−2	−2	−2	0	−1
Income before tax	−45	−27	−15	−6	−6	−10	−6	−4	−5	−7	−8	−4
Income tax expense	0	−1	0	0	0	0	0	0	0	0	0	0
Net income from continuing operations	−46	−27	−15	−6	−6	−10	−6	−4	−5	−7	−8	−4
Net income	−46	−27	−15	−6	−6	−10	−6	−4	−5	−7	−8	−4
EPS, basic	−$1.97	−$1.14	−$0.62	−$0.24	−$0.25	−$0.41	−$0.25	−$0.15	−$0.20	−$0.26	−$0.30	−$0.14
EPS, diluted	−$1.97	−$1.14	−$0.62	−$0.24	−$0.25	−$0.41	−$0.25	−$0.15	−$0.20	−$0.26	−$0.30	−$0.14
Weighted average shares, basic	23	23	23	24	24	24	25	27	26	27	27	27
Weighted average shares, diluted	23	23	23	24	24	24	25	27	26	27	27	27
EBITDA	−9	−22	−9	0	−1	−5	−1	1	0	−2	−4	−1
Depreciation & amortization	5	5	5	5	5	5	5	5	5	5	5	3
EBIT	−14	−27	−15	−6	−6	−10	−6	−4	−5	−7	−8	−4